Artivion, Inc. (NYSE: AORT), a prominent player in cardiac and vascular surgery, announced its participation in the forthcoming Morgan Stanley 23rd Annual Global Healthcare...
In a recent filing with the Securities and Exchange Commission, 325 Capital LLC disclosed it has reduced its holdings in PowerFleet, Inc. (NASDAQ: AIOT)...
Moderna, Inc. has announced that five of its abstracts focusing on investigational mRNA therapeutics will be presented at the upcoming 2025 International Congress of...
DoorDash, Inc. (NASDAQ:DASH) saw a significant stock transaction on August 26, 2023, when its Chief Financial Officer, Ravi Inukonda, sold 13,891 shares of the...
Globus Medical, Inc. has achieved a significant legal victory against Life Spine, Inc., following a ruling from a Delaware jury that affirmed the validity...
Urban Outfitters, Inc. (NASDAQ: URBN) has announced a record net income of $143.9 million, or $1.58 per diluted share, for its fiscal second quarter,...
UPDATE: BitMine Immersion Technologies, Inc. (BMNR) shares have plunged 2.22% in after-hours trading as Ethereum (ETH) experiences a significant pullback. This decline comes despite...
Each summer, a select group of high school graduates embarks on a transformative journey through the Holz Technik Registered Apprenticeship Program in Jersey City,...
Madrigal Pharmaceuticals, Inc. has granted equity inducement awards to 11 non-executive employees as part of its 2025 Inducement Plan. The awards, which were approved...
Shares of CrowdStrike Holdings, Inc. (NASDAQ: CRWD) decreased by 1.6% on Tuesday, following a downgrade from Evercore ISI, which reduced its price target for...
Smart Sand, Inc. (NASDAQ: SND) demonstrated significant sales growth in the second quarter of 2025, reporting revenues of $85.8 million, an increase from $65.6...
Vanguard Group Inc. has reduced its stake in PENN Entertainment, Inc. (NASDAQ:PENN) by 0.7% during the first quarter of 2023, according to the firm’s...
Orchestra BioMed Holdings, Inc. has released significant clinical findings indicating that its atrioventricular interval modulation (AVIM) therapy could markedly enhance heart function in patients...
Mineralys Therapeutics, Inc. (Nasdaq: MLYS) is progressing towards filing a new drug application (NDA) for its leading drug candidate, lorundrostat, following a series of...
Equities researchers at Taglich Brothers have projected a challenging financial outlook for BGSF, Inc. (NYSE:BGSF) in their recent report. According to a research note...